Skip to main content
    C

    Citius Pharmaceuticals Inc (CTXR)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.53
    -0.01 (-1.40%)

    Market Cap: $14.69M

    Last updated: Nov 17, 2026 at 11:00 AM ET

    Citius Pharmaceuticals Inc (CTXR) Earnings: Report Dates and Results

    Updated Aug 14, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    Citius Pharmaceuticals (CTXR) is expected to report earnings on Dec 21, 2026. In the quarter ended Jun 30, 2026, Citius Pharmaceuticals reported EPS of -$0.34, above the -$0.36 estimate. It beat the EPS estimate in 2 of the 8 most recent quarters that had an estimate.

    Earnings

    Performance (10Y)

    Beat Rate
    34%(11/32)
    Avg Surprise
    -35.93%
    Streak
    1 Q

    Upcoming Estimates

    Reports Dec 21, 2026 (est.)Period ending Sep 30, 2026
    EPS Consensus-$0.42
    RangeN/A
    3 analysts
    Revenue Consensus
    $3.00M
    Range$2.89M - $3.09M
    3 analysts
    Reports Feb 11, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus-$0.38
    Range-$0.38 - -$0.38
    1 analysts
    EPS RevisionsNo revisions (30d)
    EPS Estimate DriftChange to current
    90d ago$0.00n/a
    60d ago$0.00n/a
    30d ago$0.00n/a
    7d ago$0.00n/a
    Current-$0.38
    Revenue Consensus
    $4.40M
    Range$4.40M - $4.40M
    1 analysts

    Next Report

    CTXR has an expected report date of Dec 21, 2026.

    Earnings History

    Of the 32 quarters below that had an estimate, CTXR beat 11, missed 16 and matched 5. The widest gap in the table came in the quarter ended Sep 30, 2024, when EPS landed 286.67% below the estimate.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReportedRevenue
    Jun 30, 2026-$0.34-$0.36-$0.36 - -$0.36+5.56%BeatN/A10 up, 0 downAug 14, 2026$1.49M
    Mar 31, 2026-$0.95-$0.32-$0.32 - -$0.32-196.88%MissN/A10 up, 0 downMay 15, 2026$1.67M
    Dec 31, 2025-$0.38-$0.30-$0.30 - -$0.30-26.67%MissN/A10 up, 0 downFeb 13, 2026$3.94M
    Sep 30, 2025-$0.11-$0.24-$0.24 - -$0.24+54.17%BeatN/A10 up, 1 downDec 25, 2025N/A
    Jun 30, 2025-$0.80-$0.21-$0.21 - -$0.21-280.95%MissN/A11 up, 0 downAug 12, 2025N/A
    Mar 31, 2025-$1.27$0.11-$1.08 - $1.30N/AN/AN/A20 up, 0 downMay 14, 2025N/A
    Dec 31, 2024-$1.30-$1.25N/A-4.00%MissN/A10 up, 0 downJan 3, 2025N/A
    Sep 30, 2024-$5.80-$1.50N/A-286.67%MissN/A10 up, 0 downDec 27, 2024$155926
    Jun 30, 2024-$1.50-$1.12-$1.50 - -$1.00-33.93%MissN/A20 up, 0 downAug 12, 2024N/A
    Mar 31, 2024-$1.25-$1.50-$1.50 - -$1.50+16.67%BeatN/A10 up, 0 downMay 14, 2024N/A
    Dec 31, 2023-$0.06$0.13$0.13 - $0.13-146.15%MissN/A10 up, 0 downFeb 14, 2024N/A
    Sep 30, 2023-$1.75-$1.50N/A-16.67%MissN/A10 up, 0 downDec 29, 2023N/A
    Jun 30, 2023-$1.50-$1.75-$1.75 - -$1.00+14.29%BeatN/A20 up, 0 downAug 14, 2023N/A
    Mar 31, 2023-$1.75-$1.25-$1.25 - -$0.50-40.00%MissN/A21 up, 0 downMay 12, 2023N/A
    Dec 31, 2022-$0.02-$0.06N/A+66.67%BeatN/AN/A0 up, 0 downFeb 10, 2023N/A
    Sep 30, 2022-$1.25-$1.50N/A+16.67%BeatN/A10 up, 0 downDec 22, 2022N/A
    Jun 30, 2022-$1.50-$1.50-$1.75 - -$0.750.00%In lineN/A30 up, 0 downAug 11, 2022N/A
    Mar 31, 2022-$1.25-$1.75-$2.00 - -$1.50+28.57%BeatN/A20 up, 0 downMay 12, 2022N/A
    Dec 31, 2021-$1.50-$1.50-$1.50 - -$1.500.00%In lineN/A10 up, 0 downFeb 10, 2022N/A
    Sep 30, 2021-$0.02-$0.04-$0.05 - -$0.03+50.00%BeatN/A20 up, 0 downDec 15, 2021N/A
    Jun 30, 2021-$1.25-$1.00N/A-25.00%MissN/A2N/AAug 12, 2021N/A
    Mar 31, 2021-$1.00-$2.25-$2.25 - -$1.50+55.56%BeatN/A2N/AMay 13, 2021N/A
    Dec 31, 2020-$0.15$0.16$0.16 - $0.16-193.75%MissN/A1N/AFeb 11, 2021N/A
    Sep 30, 2020-$1.75-$2.50-$2.75 - -$2.50+30.00%BeatN/A2N/ADec 16, 2020N/A
    Jun 30, 2020-$2.75-$2.75-$2.75 - -$2.500.00%In lineN/A2N/AAug 14, 2020N/A
    Mar 31, 2020-$3.25-$2.75-$2.75 - -$2.25-18.18%MissN/A2N/AMay 14, 2020N/A
    Dec 31, 2019-$3.75-$3.50-$3.50 - -$3.50-7.14%MissN/A1N/AFeb 13, 2020N/A
    Sep 30, 2019-$0.16-$0.14-$0.14 - -$0.14-14.29%MissN/A1N/ADec 16, 2019N/A
    Jun 30, 2019-$5.00-$1.50N/A-233.33%MissN/AN/AN/AAug 14, 2019N/A
    Mar 31, 2019-$5.00-$5.00-$5.00 - -$5.000.00%In lineN/A1N/AMay 15, 2019N/A
    Dec 31, 2018-$5.50-$5.25N/A-4.76%MissN/AN/AN/AFeb 14, 2019N/A
    Sep 30, 2018-$0.16-$0.16N/A0.00%In lineN/AN/AN/ADec 11, 2018N/A
    Jun 30, 2018-$4.75-$8.00-$8.00 - -$8.00+40.63%BeatN/A1N/AAug 14, 2018N/A
    Mar 31, 2018-$0.44N/AN/AN/AN/AN/AN/AN/AMay 11, 2018N/A
    Dec 31, 2017-$0.38N/AN/AN/AN/AN/AN/AN/AMar 20, 2018N/A
    Sep 30, 2017-$0.43N/AN/AN/AN/AN/AN/AN/ADec 13, 2017N/A
    Jun 30, 2017-$0.49N/AN/AN/AN/AN/AN/AN/AAug 14, 2017N/A
    Mar 31, 2017-$0.55N/AN/AN/AN/AN/AN/AN/AMay 15, 2017N/A
    Dec 31, 2016-$11.09N/AN/AN/AN/AN/AN/AN/AFeb 14, 2017N/A
    Sep 30, 2016-$13.28N/AN/AN/AN/AN/AN/AN/ADec 23, 2016N/A
    Last 40 quarters

    Annual EPS

    EPS for the fiscal year ended Sep 30, 2026 was -$1.67, after -$3.48 the year before. It was -$12.56 for the year ended Sep 30, 2017, the oldest of the 10 fiscal years shown.

    Fiscal year endedEPSChange
    Sep 30, 2026-$1.67N/A
    Sep 30, 2025-$3.48N/A
    Sep 30, 2024-$8.61N/A
    Sep 30, 2023-$5.02N/A
    Sep 30, 2022-$5.50N/A
    Sep 30, 2021-$2.42N/A
    Sep 30, 2020-$11.50N/A
    Sep 30, 2019-$15.66N/A
    Sep 30, 2018-$5.73N/A
    Sep 30, 2017-$12.56N/A

    Frequently Asked Questions About CTXR

    When is Citius Pharmaceuticals's next earnings date?

    Citius Pharmaceuticals's next earnings report is expected for Dec 21, 2026.

    Did CTXR beat earnings estimates last quarter?

    Yes. Citius Pharmaceuticals reported EPS of -$0.34 for the quarter ended Jun 30, 2026, above the -$0.36 estimate, a 5.56% surprise.

    What EPS do analysts expect from CTXR next quarter?

    The consensus EPS estimate for Citius Pharmaceuticals for the quarter ended Sep 30, 2026 is -$0.42 from 3 analysts.

    How often does CTXR beat earnings estimates?

    Citius Pharmaceuticals beat the EPS estimate in 2 of the 8 most recent quarters that had an estimate, with an average surprise of -96.17%.